sglt2 inhibitors and glp-1 receptor agonists together in Diabetic Kidney Disease: Evolving Evidence and Clinical Application GLP1 Receptor Agonists vs SGLT2-I

If the influence of covariates was involved, adjustments were made through the inverse operation of the covariate formula to mitigate the effects of uneven distribution across different studies owing to covariate effects

JCI Insight 8 , e170671 (2023)

41 Similarly, Aronne et al reported that in overweight or obese individuals, most of the weight lost during tirzepatide therapy was regained after treatment discontinuation

Youll be able to find clinical trials at all different phases, including: New, not yet recruiting Active, recruiting Active, not recruiting Completed One thing to keep in mind: Clinicaltrials.gov is maintained by The National Library of Medicine (NLM), but the government doesnt review or approve the safety of the clinical trials

Decision: immediate discontinuation of the drug